longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Yili Chuanning Bio

301301

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 30.86, above the reasonable range, cheaper than 16.6% of the time in the past 3 years, and the industry ranks 14/85, the industry Median 11.12.

30.86xP/E
¥8.18Stock price
¥0.27Earnings per share
30.86xP/E
Stock price¥8.18Earnings per share¥0.27

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
23.77x
Typical range
20.43x–28.69x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.12x
03774111148

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.12x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
603087SHGan & Lee
34.47x24.52%¥39.63B
002252SZShanghai RAAS
26.68x16.67%¥32.24B
300896SZIMEIK
24.23x2.02%¥26.53B
600161SHBTBP
31.57x6.67%¥23.91B
002007SZHUALAN BIOLOGICAL
28.93x4.14%¥23.37B
301301SZYili Chuanning Bio
30.86x20.59%¥18.26B
000403SZPLBIO
35.60x213.64%¥9.53B
300406SZBSBE
29.31x121.88%¥6.59B
300841SZKanghua Biological
25.65x22.92%¥6.32B
002880SZWEIGUANG BIOLOGICAL
25.46x20.82%¥4.66B
603739SHVland Biotech
38.83x25.00%¥3.17B
300653SZZHBIO
38.20x20.65%¥2.66B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.